GSK plc
GLAXF · OTC
10/28/2025 | 9/30/2025 | 6/30/2025 | 3/31/2025 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,714,163 | – | $1,646,000 | $1,772,000 |
| Dep. & Amort. | $995,058 | – | $1,159,000 | $823,000 |
| Deferred Tax | $0 | – | $0 | $0 |
| Stock-Based Comp. | $0 | – | $0 | $0 |
| Change in WC | -$1,066,803 | – | -$1,031,000 | -$788,000 |
| Other Non-Cash | $385,162 | – | $322,000 | -$662,000 |
| Operating Cash Flow | $3,027,581 | – | $2,096,000 | $1,145,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,202,891 | – | -$256,000 | -$208,000 |
| Net Acquisitions | -$1,154,307 | – | -$36,000 | -$826,000 |
| Inv. Purchases | -$10,819 | – | $0 | $0 |
| Inv. Sales/Matur. | $174,397 | – | $0 | $0 |
| Other Inv. Act. | $43,508 | – | -$333,000 | -$110,000 |
| Investing Cash Flow | -$2,150,112 | – | -$625,000 | -$1,144,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$78,535 | – | -$874,000 | $1,918,000 |
| Stock Issued | $477 | – | $2,000 | $12,000 |
| Stock Repurch. | -$448,047 | – | -$561,000 | -$247,000 |
| Dividends Paid | -$905,469 | – | -$656,000 | -$612,000 |
| Other Fin. Act. | -$275,122 | – | -$283,000 | -$213,000 |
| Financing Cash Flow | -$1,706,696 | – | -$2,372,000 | $858,000 |
| Forex Effect | $334,577 | – | -$26,000 | -$11,000 |
| Net Chg. in Cash | -$494,650 | – | -$927,000 | $848,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,931,890 | – | $4,251,000 | $3,403,000 |
| End Cash | $4,437,240 | – | $3,324,000 | $4,251,000 |
| Free Cash Flow | $2,599,208 | – | $1,463,000 | $697,000 |